Test Code TOBPA Tobramycin, Peak, Serum
Reporting Name
Tobramycin, Peak, SPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Monitoring adequacy of serum concentration during tobramycin therapy
Method Name
Immunoassay
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Serum gel tubes should be centrifuged within 2 hours of collection.
2. Red-top tubes should be centrifuged, and the serum aliquoted into a plastic vial within 2 hours of collection.
Specimen Type
SerumSpecimen Minimum Volume
0.25 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 7 days | |
Frozen | 28 days | ||
Ambient | 72 hours |
Reject Due To
Gross hemolysis | Reject |
Reference Values
Therapeutic: 3.0-12.0 mcg/mL
Toxic: >12.0 mcg/mL
Interpretation
Target peak concentrations depend on the type of infection being treated. Peak levels for most infections using conventional dosing are 3.0 to 12.0 mcg/mL. Prolonged exposure to peak concentrations exceeding 12.0 mcg/mL may lead to toxicity.
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 to 2 daysTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
80200
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
TOBPA | Tobramycin, Peak, S | 4057-6 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
TOBPA | Tobramycin, Peak, S | 4057-6 |
Forms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.